Year 2020 and 2019 In the third quarter of the year 2020, the Company had the net profit attributable to equity holders of the Company in the amount of Baht 822 Million, when compared to net profit of
quarter of 2019, the Company’s revenues were 5,979 million baht, showing an increase of 754 million baht or 14% y-y and 6% q-q. This was the result of continued growth in core business revenues that
Commission governing the maintenance of financial status of a licensed securities company; (2) shareholders’ equity as shown in the latest financial statement that has been audited by an auditor approved by
) shareholders’ equity as shown in the latest financial statement that has been audited by an auditor approved by the Office shall be positive. In case where the securities company increase its paid-up capital
governing the maintenance of financial status of a licensed derivatives broker; (2) shareholders’ equity as shown in the latest financial statement that has been audited by an auditor approved by the Office
of the Securities and Exchange Commission governing the maintenance of financial status of a licensed derivatives broker; (2) shareholders’ equity as shown in the latest financial statement that has
2017. This was mainly due to the reduction of advertising budgets that have been allocated from the advertising agency to the subsidiary's channel was reduced. As a result of the debtor’s management of
% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share